Cargando…

Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations

Detalles Bibliográficos
Autores principales:	Angeli, Fabio, Reboldi, Gianpaolo, Spanevello, Antonio, De Ponti, Roberto, Visca, Dina, Marazzato, Jacopo, Zappa, Martina, Trapasso, Monica, Masnaghetti, Sergio, Fabbri, Leonardo M., Verdecchia, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514650/ https://www.ncbi.nlm.nih.gov/pubmed/34670682 http://dx.doi.org/10.1016/j.ejim.2021.10.006

Ejemplares similares

Electrocardiographic features of patients with COVID-19 pneumonia
por: Angeli, Fabio, et al.
Publicado: (2020)

Combined Use of Electrocardiography and Ultrasound to Detect Cardiac and Pulmonary Involvement after Recovery from COVID-19 Pneumonia: A Case Series
por: Marazzato, Jacopo, et al.
Publicado: (2021)

Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study
por: Marazzato, Jacopo, et al.
Publicado: (2021)

COVID-19, vaccines and deficiency of ACE(2) and other angiotensinases. Closing the loop on the "Spike effect"
por: Angeli, Fabio, et al.
Publicado: (2022)

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later
por: Angeli, Fabio, et al.
Publicado: (2021)

The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure()
por: Angeli, Fabio, et al.
Publicado: (2023)

SARS-CoV-2 vaccines: Lights and shadows
por: Angeli, Fabio, et al.
Publicado: (2021)

Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis
por: Angeli, Fabio, et al.
Publicado: (2022)

Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine
por: Zappa, Martina, et al.
Publicado: (2021)

Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin?()
por: Angeli, Fabio, et al.
Publicado: (2023)

Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry
por: Angeli, Fabio, et al.
Publicado: (2019)

Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines
por: Zappa, Martina, et al.
Publicado: (2022)

mRNA Metabolism and Hypertension
por: Zappa, Martina, et al.
Publicado: (2023)

Complications of SARS-CoV-2 Infection During Cardiac Rehabilitation: A Case Series
por: Zappa, Martina, et al.
Publicado: (2023)

Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
por: Angeli, Fabio, et al.
Publicado: (2021)

Blood pressure increase during hospitalization for COVID-19
por: Angeli, Fabio, et al.
Publicado: (2022)

Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients
por: Marazzato, Jacopo, et al.
Publicado: (2022)

Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
por: Reboldi, Gianpaolo, et al.
Publicado: (2009)

Pulmonary Rehabilitation and Asthma
por: Zampogna, Elisabetta, et al.
Publicado: (2020)

Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation
por: Angeli, Fabio, et al.
Publicado: (2019)

Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The ‘Ambulatory Does Prediction Valid (ADPV)’ Approach
por: Angeli, Fabio, et al.
Publicado: (2023)

Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19
por: Angeli, Fabio, et al.
Publicado: (2021)

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction
por: Verdecchia, Paolo, et al.
Publicado: (2008)

Diuretic Treatment of Hypertension
por: Grossman, Ehud, et al.
Publicado: (2011)

Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons
por: Verdecchia, Paolo, et al.
Publicado: (2014)

Novel Electrocardiographic Patterns for the Prediction of Hypertensive Disorders of Pregnancy—From Pathophysiology to Practical Implications
por: Angeli, Fabio, et al.
Publicado: (2015)

Knowing the new Omicron BA.2.75 variant (‘Centaurus’): A simulation study
por: Zappa, Martina, et al.
Publicado: (2022)

Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16
por: Zappa, Martina, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variant
por: Zappa, Martina, et al.
Publicado: (2023)

Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2
por: Angeli, Fabio, et al.
Publicado: (2023)

Comparative assessment of angiotensin receptor blockers in different clinical settings
por: Verdecchia, Paolo, et al.
Publicado: (2009)

The revolution of the anti-diabetic drugs in cardiology
por: Verdecchia, Paolo, et al.
Publicado: (2020)

Echocardiography in Low‐Risk Hypertensive Patients
por: Mancusi, Costantino, et al.
Publicado: (2019)

Procedural Feasibility and Long-Term Efficacy of Catheter Ablation of Atypical Atrial Flutters in a Wide Spectrum of Heart Diseases: An Updated Clinical Overview
por: De Ponti, Roberto, et al.
Publicado: (2022)

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
por: Verdecchia, Paolo, et al.
Publicado: (2020)

Management of chronic refractory cough in adults
por: Visca, Dina, et al.
Publicado: (2020)

High-Sensitivity Cardiac Troponin T and the Diagnosis of Cardiovascular Disease in the Emergency Room: The Importance of Combining Cardiovascular Biomarkers with Clinical Data
por: Golino, Michele, et al.
Publicado: (2022)

Transseptal Catheterization With a New Septal Device Implanted: A Paradoxically Complex Procedure When the Door Is Wide Open?
por: De Ponti, Roberto, et al.
Publicado: (2021)

Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
por: Vedovati, Maria Cristina, et al.
Publicado: (2019)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
por: Angeli, Fabio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_smt2u4g97vbo17d81quq9cbtu3